Evidence map›Paper›PMID 33834161›Full record

ArticleJournal of obesity and chronic diseases2021

Effects of High-Fructose Diet

Amit Kumar, Ronald A Lubet, Jennifer T Fox, William G Nelson, Harold Seifried, Clinton J Grubbs, Mark Steven Miller

Open access · diamondAbstract read
In one paragraph

Article in Journal of obesity and chronic diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Amit Kumar *Nutritional Science Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD.
Ronald A Lubet *Chemopreventive Agent Development Research Group, Division of Cancer Prevention, Rockville, MD.
Jennifer T FoxChemopreventive Agent Development Research Group, Division of Cancer Prevention, Rockville, MD.
William G NelsonDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD.
Harold SeifriedNutritional Science Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD.
Clinton J GrubbsDepartment of Surgery, University of Alabama at Birmingham, Birmingham, AL.
Mark Steven MillerChemopreventive Agent Development Research Group, Division of Cancer Prevention, Rockville, MD.
Sensor Research and Development Corporation (United States) · USNational Cancer Institute · USJohns Hopkins University · USUniversity of Alabama at Birmingham · US

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILLIAM George NELSON · 1985 to 2026
$208.6M
Intramural NIH HHS Z99 CA999999NCI NIH HHS HHSN261201200021INCI NIH HHS P30 CA006973
6 · The paper itself

Abstract

Epidemiology, clinical and experimental animal studies suggest high fructose diets are detrimental to metabolic status and may contribute to tumor development. This due to increased obesity and metabolic syndrome, known risk factors for many types of cancer. We compared tumor development in N-methyl-N-nitrosourea (MNU)-treated rats fed either a high (60%)-fructose diet (HFD) or a standard diet (SD). Female Sprague-Dawley rats at 43 days of age (DOA) were fed a SD or HFD followed by administration of MNU at 50 DOA. Rats were palpated weekly and sacrificed at 190 DOA. MNU-treated rats on HFD exhibited decreased tumor latency and roughly a two-fold increase in tumor multiplicity. RNA-Seq on frozen tumors (SD

Indexed as

High-fructose dietMammary cancerPrevention

Identifiers

PMID33834161
PMCPMC8026172
OpenAlexW3145914378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.